-
1. Cutler, N. R.; Polinsky, R. J.; Sramek, J. J.; Enz, A.; Jhee, S. S.; Mancione, L.; Hourani, J.; Zolnouni, P. Acta Neurol. Scand. 1998, 97(4), 244–50.
-
2. Gottwald, M. D.; Rozanski, R. I. Expert Opin. Investig. Drugs 1999, 8(10), 1673–82.
-
3. Greig, N. H.; Utsuki, T.; Yu, Q.; Zhu, X.; Holloway, H. W.; Perry, T.; Lee, B.; Ingram, D. K.; Lahiri, D. K. Curr. Med. Res. Opin. 2001, 17(3), 159–65.
-
4. Ballard, C. G. Eur. Neurol. 2002, 47(1), 64–70.
-
5. Enz, A.; Chappuis, A.; Dattler, A. Biomed. Chromatogr. 2004, 18(3), 160–6.
-
6. FDA. US Department of Health and Human Services, Food and Drug Administration. Guidance for industry, bioanalytical method validation, 2018. https://www.fda.gov/media/70858/download (accessed July 23, 2021).
-
7. EMA. European Medicines Agency. Guideline on bioanalytical method validation, 2012. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500109686.pdf (accessed July 23, 2021).
-
8. Karasova, J. Z.; Hrabinova, M.; Krejciova, M.; Jun, D.; Kuca, K. Iran J. Pharm. 2020, 19, 95–102.
-
9. Nakamura, Y.; Imai, Y.; Shigeta, M.; Graf, A.; Shirahase, T.; Kim, H.; Fujii, A.; Mori, J.; Homma, A. Dement. Geriatr. Cogn. Dis. Extra. 2011, 1(1), 163–79.
-
10. Ueda, K.; Katayama, S.; Arai, T.; Furuta, N.; Ikebe, S.; Ishida, Y.; Kanaya, K.; Ouma, S.; Sakurai, H.; Sugitani, M.; Takahashi, M.; Tanaka, T.; Tsuno, N.; Wakutani, Y.; Shekhawat, A.; Das Gupta, A.; Kiyose, K.; Toriyama, K.; Nakamura, Y. Dement. Geriatr. Cogn. Dis. Extra. 2019, 9(2), 302–18.